Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Fengfeng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, Key Laboratory of Surveillanc…. Hauptthemen laut MEDLINE: Hand, Foot and Mouth Disease, Vaccination Coverage, Viral Vaccines, Enterovirus A, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The burden of hand, foot, and mouth disease (HFMD) in children under five is substantial, with the greatest burden in China. Most cases are mild, although some are severe and even fatal. A vaccine against EV‐A71, the pathogen most commonly associated with severe HFMD, was licensed in China in Dec 2015 but not introduced into the National Immunisation Programme (NIP). It was hence not covered by routine national vaccine surveillance and its coverage remained unknown for the years following its initial licensure. Here we report the results of a novel data collection and analysis approach to address this knowledge gap. Local public health entities were invited to report county‐specific numbers of EV‐A71 vaccine doses administered between 2016 and 2019 in mainland China. A cohort model was then used to estimate vaccine coverage. The association between county‐level factors (epidemiological, socioeconomic, demographic, and environmental) and vaccine coverage was assessed using zero‐inflated beta regression models. We received responses from 2,248 out of 3,252 counties in 23 of 31provinces in mainland China. The median county‐level EV‐A71 vaccine coverage was 10.17% [IQR: 3.50%, 19.39%] in 2018 and 16.70% [IQR: 8.78%, 27.45%] in 2019. However, the median absolute differences in coverage (i.e., max‐min) within‐prefecture were ~30%. Results from the regression model indicate that low vaccine coverage was associated with low socioeconomic status, small populations and high proportions of young children. Coverage of EV‐A71 vaccines was low in China prior to the COVID‐19 pandemic, with substantial geographical disparities over 4 years after the initial vaccine licensure. Our results illustrate the private market response to a new childhood vaccine that is licensed but not centrally funded. Despite economic growth, vaccine coverage among marginalised populations will likely be low without targeted policy and financial support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease…
- Department of Health Policy and Management, School of Public Health, Peking University, Beijing, PR China.
- Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education.
- Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, PR China.
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, PR China.
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
ORCID-Profile: Fuqiang Cui
Zitieren
APA
Liu, F., Cui, F., Quilty, B. J., Song, Y., Tong, X., Flasche, S., Jit, M., Li, Z., Chang, Z., & Liu, Y. (2026). Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease. Journal of Medical Virology. https://doi.org/10.1002/jmv.70776
Vancouver
Liu F, Cui F, Quilty BJ, Song Y, Tong X, Flasche S, et al. Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease. Journal of Medical Virology. 2026. doi:10.1002/jmv.70776
BibTeX
@article{Liu2026,
author = {Liu, Fengfeng and Cui, Fuqiang and Quilty, Billy J and Song, Yang and Tong, Xin and Flasche, Stefan and Jit, Mark and Li, Zhongjie and Chang, Zhaorui and Liu, Yang},
title = {Estimating the Uptake of and Factors Associated With a New Vaccine Outside of the National Immunisation Programme: A Case Study of the EV‐A71 Vaccine Against Hand, Foot, and Mouth Disease},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70776}
}
EUVIMED